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Background: Public health aims to provide universal safety and progressive opportunities to populations to realise
their highest level of health through prevention of disease, its progression or transmission. Screening asymptomatic
individuals to detect early unapparent conditions is an important public health intervention strategy. It may be
designed to be compulsory or voluntary depending on the epidemiological characteristics of the disease.
Integrated screening, including for both syphilis and cancer of the cervix, is a core component of the national
reproductive health program in Kenya. Screening for syphilis is compulsory while it is voluntary for cervical cancer.
Participants’ perspectives of either form of screening approach provide the necessary contextual information that
clarifies mundane community concerns.
Methods: Focus group discussions with female clients screened for syphilis and cancer of the cervix were
conducted to elicit their perspectives of compulsory and voluntary screening. The discussions were audiotaped,
transcribed and thematic content analysis performed manually to explore emerging ethics issues.
Results: The results indicate that real ethical challenges exist in either of the approaches. Also, participants were
more concerned about the benefits of the procedure and whether their dignity is respected than the
compulsoriness of screening per se. The implication is for the policy makers to clarify in the guidelines how to
manage ethical challenges, while at the operational level, providers need to be judicious to minimize potential
harms participants and families when screening for disease in women.
Conclusions: The context for mounting screening as a public health intervention and attendant ethical issues may
be more complex than hitherto perceived. Interpreting emerging ethics issues in screening requires more nuanced
considerations of individuals’ contextual experiences since these may be contradictory to the policy position. In
considering mounting screening for Syphilis and cervical cancer as a public heal intervention, the community
interests and perspectives should be inculcated into the program. Population lack of information on procedures
may influence adversely the demand for screening services by the individuals at risk or the community as a
collective agent.
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Public health aims to provide universal safety and pro-
gressive opportunities to populations to realise their
highest level of health through prevention of disease, its
progression or transmission [1]. Screening as a public
health strategy entails early detection of disease or its
precursors in asymptomatic populations deemed to be at
risk [2-5]. Its key objectives and rationale include detect-
ing diseases early when treatment is more cost-effective;
identifying disease predisposing factors and appropriate
management of identified risk factors [2,3]. Depending
on the epidemiological characteristics of the disease, de-
fined by its occurrence and resource availability for care
and management, screening may be mounted as volun-
tary or mandatory national program with a long-term
aim of reducing morbidity and mortality [2,6-8].
The process of screening to detect early different dis-
eases inherently is fraught with diverse ethical challenges
[6,9]. However, analysis of these challenges may be tax-
ing to decision-makers and service providers since ethics
constructs for considering public health practice are
varied [10,11]. Ethical analysis is needed to clarify the
contextual level of public health necessity as well as
evaluate the rationale for, prioritize and justify activ-
ities designed to accomplish the stated public health
objectives [12]. Policies on screening for syphilis and
cancer of the cervix in Kenya vary given their epi-
demiological as well as medical characteristics [13-16].
They were considered simultaneously in the current
study to help clarify ethical issues in screening for
them based on the perceptions of women undergoing
the process.
Epidemiological and policy context for screening in Kenya
The prevalence of antenatal syphilis in Kenya is esti-
mated at 3.8% and more than half of these develop un-
favorable obstetric outcomes, such as maternal deaths,
prolonged morbidity and congenital fetal syphilis. Un-
treated syphilis pose high threats to the general popula-
tion because of its potential for an outbreak [17,18].
Screening for maternal syphilis early in the first trimes-
ter is a mandatory exercise aimed at minimizing the ad-
verse outcomes to the mother and the unborn child as
well as to control disease spread or potential epidemics
in the general population. This is plausible since syphilis
is an infectious but preventable and easily treatable dis-
ease, although on the other hand, this may be perceived
as a way of compulsion and control. While sufficient
service coverage is necessary, apparently few antenatal
mothers access these services as stipulated given that
majority of women in Kenya initiate antenatal clinic
visits late (at a mean gestation of 5.9 months). Even
then, less than one third of receive relevant informa-
tion and fewer ever obtain blood tests [19].Cervical cancer on the other hand, is the leading cause
of reproductive tract cancers in Kenya. It is associated
with high morbidity and mortality burden among women
at risk yet it is largely preventable and can be effect-
ively treated if detected early [7]. Consequently, its pre-
vention through health promotion and education activities,
early detection through screening and effective man-
agement of cases has been prioritized in the National
Reproductive Health Strategy. The national operational
guidelines are available to enhance procedure administra-
tion. It is stipulated that providers should take informed
consent and document adequate reproductive health
history during screening. Additionally, after the proce-
dures results as well as plans for return visits should be
discussed with the client. These steps help to improve both
clients’ pre- and post-screening psycho-cognitive status
[20]. However, it is still unclear how patients experience
screening procedures/services vis-à-vis their perceptions/
experiences of cervical cancer.
As the Kenya national public health policy goals evolve,
elimination of disease [21]; community participation [22];
promotion of effective, accessible, acceptable and afford-
able quality health services [23] and enhanced regulatory
capacity of Ministry of Health (MoH) have been critical
[24]. The recent national health guidelines [7,20,22-26]
have progressively adopted a life-cycle, rights-based essen-
tial health care, presuming the right to ‘the highest attain-
able standard of health’ for everyone. The core values of a
rights-based approach include fairness, respect, equality,
dignity and autonomy [27] as well as accountability and
community participation [28].
Under the national reproductive health program [29]
whose aim is to improve maternal health; reduce neonatal/
child mortality and morbidity; reduce the spread of HIV/
AIDS and promote empowerment of women, integrated
screening, including for both syphilis and cancer of the
cervix, has been incorporated as part of the essential health
package [20]. These services are largely integrated within
the existing outpatient departments [29], maternity units
and comprehensive care clinics at all health service tiers
[7,30]. Specifically for syphilis, the Public Health Act in
Chapters 45 (a) – (c), 48 and 51 provides for mandatory
surveillance to identify localities of high disease prevalence
and undertaking of appropriate medical and public health
interventions. However, the Act also provides that services
must be provided in the context of informed consent, priv-
acy, confidentiality, information, education and appropriate
communication. Further, a client or her partner(s) must be
notified once the disease is diagnosed and provided with
written instructions about the condition, appropriate edu-
cation and counseling while, ensuring strict privacy and
confidentiality of their medical records [7,31].
There are challenges in studying or implementing pro-
grams for Syphilis and cervical cancer given they are
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logical status may be harmed by positive results due to
loss of personal and social esteem, stigma, anxiety and
fetal loss, among others. On the other hand, curveillance
and disease notification within the context of screening
are necessary in identifying proportionate distributions
of disease burden in populations as well as the level of
prevention and care resources required [10,12]. The fun-
damental policy and operational challenge remains how to
achieve a balance in effective population coverage while
minimizing potential harms to individuals or communities
[32]. These potential harms have not been sufficiently ex-
plored in Kenya. This study sought to explore women’s
perception of mandatory screening for syphilis and volun-
tary screening of cervical cancer in Nyanza, Kenya with an
aim to identify evolving ethical issues. The results high-
light local interpretative notions useful for progressive
planning and implementation decisions [33,34].
Methods
Study design and survey instruments
This qualitative study was conducted in 2009 among cli-
ents attending cervical cancer and antenatal clinics in
Nyanza Provincial hospital; Kisumu District hospital and
Lumumba Municipal health center, all within Kisumu
City. The purpose was to explore ethics issues related to
both compulsory and voluntary screening from clients’
perspectives. Focus Group Discussions (FGDs) were con-
ducted using interview guides adapted from the ‘Alliance
for Cervical Cancer Prevention - Reproductive Health
Reports Number 4, July 2001(ACCP) [13] which con-
tains standard questions for evaluating cervical cancer
screening in the developing world.
Discussion points, among other issues, included the
participants’ knowledge of the target disease; concerns
about developing the disease; perceptions of their own
personal risk of Cancer of the cervix or Syphilis and ac-
ceptable options for preventions respectively; their moti-
vations to attend screening clinics; disease expectancies
(specifically related to their beliefs about the source and
consequences of the disease); communicating risk and test
results to family members; perceptions, feelings, concerns
and experiences during screening either for Syphilis or
Cancer of the cervix; repeat tests, privacy, confidentiality
and access to services. The FGDs were tape-recorded
and supplemented with back-up observer notes (which
captured in summary important relevant issues, such as
emotional contents, demeanor and overall ‘feelings’ of the
focus group).
Eligibility and recruitment procedure
Participants were recruited over three weeks through a
two stage process (to minimize potential for coercion).
First, the service providers sensitized their clients aboutthe study, giving only basic information about the study.
This was to give all clients undergoing the tests an oppor-
tunity to choose to participate, while avoiding potentially
biased approach by study staff. Subsequently, those who
were willing to participate in a discussion group were re-
ferred (using a study referral note) to the research assis-
tants sitting in a different room. It was considered that
those who presented to the study staff were truly willing to
participate. However, the study staff conducted consenting
to every client individually by providing in-depth informa-
tion about the study and answering questions arising.
Those willing to participate in the focus group pro-
vided written consent. Only females aged at least 18 years
and had been tested for Syphilis or undergone cervical
cancer screening that day were consented and enrolled.
During consenting, everyone was assured of confidenti-
ality and privacy; informed that their voices will be
audio-tapped and that they should not use their names
during the discussions. Each was assigned a unique num-
ber to use during the focus group discussions. Five to
eight participants were enrolled sequentially into each
focus group. Recruitment was stopped when no new or
relevant data seemed to emerge from further interviews.
Sixty four women participated in these focus group dis-
cussions. Two assistants, a moderator and note taker con-
ducted the group discussions.
Each session lasted about 45 – 60 minutes. Kiswahili
(one of the national languages) was the primary language
of communication, since majority understood it well. All
focus groups were conducted within the facility on the
same day participants were recruited. Building consensus
on sessions’ ground rules, and conducting the sessions
in a secluded place by female research assistants helped
particularly to reassure participants. A snack was provided
to participants during the session. No other compensation
was provided. After each session, the research assistants
alerted the service provider who then promptly attended
to the client in case they were not yet through with any of
the clinic procedure such as getting feedback, to avoid fur-
ther inconvenience.
All regulatory and administrative approvals were granted
by the Ethics Review Committee (ERC) at University of
KwaZulu Natal (school of psychology) and Kenya’s
National Council for Science and Technology (NCST).
Also, relevant authorizing officers from the Ministries of
Health headquarters, Provincial administration at the dis-
trict level, public health department at the Kisumu City
council, Nyanza Provincial and Kisumu district hospitals
endorsed copies of the approval letters and filed them.
Analysis
The moderator for each group transcribed and trans-
lated the audio-recordings into English. The first au-
thor [DO] reviewed every transcription to confirm
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recordings. During the translation, we tried to keep
the phrases and words as in the spoken language, to
capture the context to the extent that is closer to the
original language; albeit, we acknowledge that some
information and features carried by the local language
might be lost when such verbal expressions are trans-
lated into English.
Thematic content analysis was performed following
Graneheim & Lundman (2004) [35]. Data were explored
manually using open codes. Transcripts were progres-
sively coded by the first author [DO] to identify emer-
ging concepts. This involved thorough reading of all
client responses in every transcribed page, while consid-
ering the field-notes. A code-book was created based on
the transcripts from the first two focus groups, and up-
dated subsequently if new concepts appeared. The codes
were subsequently reviewed again by DO purposely to
identify and refine the relationship among the codes and
subsequently categorize them broadly based on conven-
tional literature to reflect important emerging ethical
concepts related to ethics of screening populations for
disease. Participant experiences and views on screening
for both Syphilis (compulsory) and Cancer of the cervix
(optional) were respectively extracted from the text
based on the derived codes, condensed and subsequently
sorted out by relevant content areas based on the overt
and latent emphases as well as their unique experiences
and expressions. Conceptual categories closely related to
ethics of screening populations for disease were devel-
oped from the resulting themes, and illustrated by se-
lected quotes.
Results
The resulting themes were organised under the following
content areas, to reflect emerging ethical issues in com-
pulsory screening for syphilis and voluntary one for cancer
of the cervix: lay knowledge and awareness of disease and
risks; information-giving at pre-screening and disclosure
of results; informed consent for the screening tests; time
burden; potential harms during the screening process; ac-
ceptance/approval of screening approach.
Participant experiences with and perspectives about
screening for syphilis as a mandatory exercise
Knowledge and awareness of syphilis, sources of risks and
its prevention
Majority of the women had satisfactory level of lay infor-
mation about Syphilis. Their main sources of knowledge
included the pre-clinical group sessions conducted by
medical staff and awareness campaign events such as
poster distribution. They understood that syphilis is an
insidious sexually transmitted disease, sometimes associ-
ated with genital wounds, and it is treatable if action istaken promptly, albeit there were notable misconcep-
tions. The following statements convey true facts
‘It is a sexually transmitted infection which is painful’
‘You can come to the hospital when pregnant or sick to
be treated for it so it does not spread to the whole body’
However, it was notable that there were misconcep-
tions indicating potential for confounded information:
‘It is transmitted by sharing pants with an infected
person or passing urine in the same place where an
infected person had urinated’;
‘If it overstays in your body, it can lead to AIDS’
Some participants also indicated that they don’t know
about the disease despite having heard about it.
‘I don’t know about it, but I have heard about it’
Participants indicated that syphilis is a dangerous dis-
ease being associated with severe adverse natal, obstetric,
medical and social sequelae. Such adversities include
barrenness, loss of fetus, strained relationship between
spouses and even death.
‘It is a dangerous disease, if you contract it you cannot
get pregnant’;
‘If a close relation has this disease, I will feel bad
because it is not good in life … I will advise her to go
to the doctor quickly before the disease worsens to a
condition she cannot walk…it can kill her so she
should go to the doctor quickly!’
They also perceived that Syphilis can be latent in the
body therefore, one should know her status by going for
medical checkup and seek treatment if found to be posi-
tive or has recognized a symptom. Alternatively, if treat-
ment fails, one could use herbs.
‘Before it is detected, you may not realize you have it;
but if you are aware, you can go to the hospital and be
treated’;
‘It affects the womb. … So it should be detected early
and treated’
Consequently, participants considered syphilis to be
worth paying attention to by individuals and entire com-
munities given it is infectious and is associated with ser-
ious adverse health and social effects.
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experiences and fear of adverse health effects, partici-
pants indicated that screening is beneficial to detect dis-
eases early hence one is able to plan for appropriate
treatment and prevention strategies. They further recog-
nized early detection can be realized through medical
check-up and recognition of symptoms based on state-
ments below.
‘Before it [Syphilis] is detected, you may not realize you
have it; but if you are aware, you can go to the
hospital and be treated’
‘You can go to the hospital to be screened then start
on medication if found to be positive’ … if it doesn’t
work, use herbs’.
If you have a genital wound, go to hospital for
screening’
Likewise they considered that ‘taking control of one’s
behavior to protect self after screening; creating aware-
ness among the community members’ about the illnesses;
use of condoms and seeking medical treatment promptly
were pragmatic responsibilities for both the individual
and whole community in managing syphilis.
Perceived advantages and potential harms of Screening
When asked about what they knew about screening for
syphilis, the participants stated that knowing one’s status
provides a reasonable basis for making sexual and repro-
ductive health decisions.
‘I know the disease exists and screening helps me in
making [a] decision before engaging in sex with a
man’
Furthermore, knowing that others have benefited from
screening may motivate uptake.
It helps people go for treatment especially when the
other people who are reluctant to go will go after they
know they are not alone in this’.
On the other hand, reporting positive disease status was
deemed a frightening experience. It heightened a sense of
fatalism, dejection, worries, agitation and apprehension,
hence need for supportive post-screening counseling.
‘If you are tested and not counseled, you can be
shocked’
Although there was general confidence about securing
the specimen through appropriate labeling, a few werestill concerned about potential for getting ‘wrong results’
in case of mix-up in specimen labeling.
‘I am satisfied with the information given after the
results because they know your results … when they
take your specimen, they label them, hence you are
sure the results you get are yours’.
Information disclosure at pre-screening and post-test
period
Pre-screening information disclosure
The discussions revealed a split in opinion and experience
about disclosure and information-giving approaches by
the health staff at the clinic. Some of the participants indi-
cated that the health staff at the clinic informed them
about Syphilis and a range of tests to be done on them.
Others also stated that their understanding about the dis-
ease had improved after undergoing the screening proced-
ure. However, some were either distracted from attention
or were not informed at all about the procedures.
Pre-screening information disclosure and counselling
was considered essential for decision-making and min-
imizing risk of severe emotional consequences that may
be associated with the process.
‘If am tested and am not counseled, maybe I can even
refuse because it will make me think that these people
are assuming I have Syphilis and if am counseled, I
can just agree to be tested’
‘I have a better understanding because they test your
status and teach you about caring [of your] private
parts’.
A few participants expressed need for prior information
about screening to facilitate involvement of spouses/sexual
partners:
‘We were not aware of it. It is better if they inform us
early so that we can involve our partners instead of
being tested alone and my partner is not there’.
Most participants considered pre-screening disclosure
helpful but preferred sessions to be interactive, private
and confidential. They expected the care-giver to pro-
vide sufficient, explicit, simple and clear information in a
manner easy to understand.
‘… [T] here is little room for interaction and some talk
too fast and clients too many to allow time for discussions
… so they want you to give other people room’
However, a few participants were indifferent and others
more critical or guarded about the benefit of the
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formation about procedures was unclear or when they
perceived that care-givers were impersonal and lacked op-
portunity to engage with them.
‘They didn’t discuss it with us; they just checked the
status, so we are blank’
‘It depends on how you find the doctor, how she/he
talks to you’.
Disclosing/sharing test results and post-test information
giving
The information given is verbal, but the results are writ-
ten in a book which the clients carry home (usually the
outpatient card). Written results were considered imper-
sonal if not verbally reinforced. There was a sense of fear
or anxiety about the outcome of the tests. Even so, a ma-
jority appreciated the fact that results are given to each
individual at a time and in private. They were also con-
tent with the level of confidentiality accorded since re-
sults are given ‘secretly’ (in private and in confidence).
‘I was happy and satisfied because we talked the two
of us and no one knew what we had talked about ’
Being aware that respective specimen bottles are la-
belled correctly enhances their confidence about the cor-
rectness of the results given, hence their trust in the
process.
‘I am satisfied with the information given after the
results because they know your results … when they
take your specimen, they label them, hence you are
sure the results you get are yours’.
But some were uneasy because of a perceived potential
for the results to be mixed up, in case there was a prob-
lem with labeling of the samples. Consequently they pre-
ferred that ‘they [staff] should not rush [in case they] give
wrong results’.
Given the prospects for psycho-emotional stress from
the test procedures, there was expectation for psycho-
logical support after the disclosure of results to help
them cope.
‘If results are positive, you should be given guidance
and counseling politely and not harshly or by throwing
words’
‘It depends on how you find the doctor, how she/he
talks to you’.
Nearly all participants underscored necessity to conduct
disclosure privately ‘with respect, dignity and politely’.They were concerned that sometimes, the staff communi-
cated the test results inappropriately. A friendlier staff
demeanor particularly a female was more preferable to
many.
Disclosure of test-outcomes to relatives
In discussing whether they would disclose the test re-
sults to their spouses or close relatives, it emerged that
confidentiality, discretion, intimacy and trust were ne-
cessary aspects in disclosing Syphilis test results, specif-
ically by the individual patient.
‘It’s better if its I who breaks the news to my husband
and not anyone else, because in the hospital we are
told the results are confidential’
‘If it’s your husband, it’s okay … because you will be
able to plan your life and know how to stay, because
you stay together and it’s important that he knows’
The picture was made complicated by the feelings re-
lated to the tests. Participants expressed acceptance and
appreciation, a sense of relief, expectation of effective treat-
ment, worries, fatalism, dejection and agitation. They felt
that the clinical area should also guarantee privacy of cli-
ents to assure their confidence:
‘I had thought about it … I knew if I had it then I was
HIV positive’
Informed consent
Opinions were varied about submitting to screening for
Syphilis during antenatal visits and whether the infor-
mation should be written or just verbal. Written con-
sent was considered necessary to authenticate decisions,
clinic visits and specify tests to significant others. How-
ever, simultaneous multiple clinical tests confounded the
context for informed consent specific for Syphilis. While a
number of respondents were aware antenatal tests for
Syphilis was mandatory, few were ready for them while
some felt providers ‘pushed’ them into it and others were
ambivalent as revealed by the statements below.
‘It is a disease that must be screened for during
pregnancy, so if you are free you just come, you don’t
wait to be told’;
‘I had made a decision to be tested before I got
pregnant, but at the clinic I was told it is a must’.
‘We were told it is a rule to undergo the test … even if
you did not come for the screening’
Nevertheless, there was broad consensus that ‘in-
formed consent’ process if conducted in privacy, accords
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fore opting for the test procedures.
‘I have two minds. One, it is good since the disease is
treatable. Two, I feel stressed, because I will be asking
myself – where did I get it from’.
While some of the clients came purposely for screen-
ing, others felt they didn’t have a choice since it is com-
pulsory for everyone who attends antenatal clinic.
Participants indicated need to clearly understand the test
processes and prospects, without being coerced or han-
dled in a manner that may impair personal judgment,
given that decision-making is a complex affair. While
some participants acknowledged improved understand-
ing of the disease, others felt that they were not prepared
initially before coming to the clinic and only obeyed
what they were told to do while others indicated they
were threatened and others were concerned with the
harsh or judgmental attitudes of the staff as revealed by
the following statements.
‘It is a disease that must be screened for during
pregnancy, so if you are free you just come, you don’t
wait to be told’;
‘We were told it is a rule to undergo the test … even if
you did not come for the screening’;
‘I had made a decision to be tested before I got
pregnant, but at the clinic I was told it is a must’
‘A fine will be imposed if [they] don’t concentrate and
later [can’t] seek for more consultations’.
Time and cost burden
Most of the participants felt the waiting time before get-
ting results was too long, sometimes running to a whole
day or several weeks, for cervical cancer screening. This
further heightened their anxieties as well as discouraging
them from coming back to the clinic for follow up. Ma-
jority of women coming for screening of cancer of the
cervix had travelled from far. Some reported the process
was complicated and took long to complete. Lack of
money to pay for some of the services and/or travelling
(cost factor) further complicated their choices for the
screening services.
Experiences during test procedures
Overall, participants highlighted diverse experiences and
feelings. On a positive note, some of them felt accepted
and appreciated during the process, conferring a sense
of relief about results and expectation to get effective
treatment. Participants who initiated screening felt more
confident the services were helpful. Nevertheless, others ex-
perienced worries, despondence and sadness. Adverse per-
ceptions or experiences during screening were reportedlythe reasons some women opted instead to seek alter-
native care from traditional midwives who do not per-
form screening. It emerged that those who ‘don’t know
their status’ and don’t attend clinic were likely to influence
others against screening.
Necessity and acceptability of repeat tests and follow-up
visits
There were varied perceptions about follow-up or repeat
examinations. While some appreciated that it may be
necessary, in case of missed detection at the initial visit,
others were not convinced of its value.
‘I can just go back if required because I don’t know
why and just in case I have the disease but it was not
detected at initial screening, so its good to know what
is happening’
Some were unhappy with it because of the potential to
feel more anxious and worried, in addition to the long
waiting time.
I can just go but asking myself “but I had already
undergone the test; why are they telling me to repeat
it?” May be I got it from somewhere!’
‘It would be difficult if [I] am going to spend the same
time waiting for results’
Others detested the whole idea because of perceived
incompetence of the process, previous adverse experi-
ence, negative attitude and potential for raised anxiety.
“I will not accept [repeat tests] because she tested me
the first time. Is it that she didn’t get it? I am not at
ease since it’s already tested …’
‘I can’t be happy because the initial results were bad.
So I can’t be sure of my life’
‘I can’t be happy because the initial results were bad.
So I can’t be sure of my life’
‘I cannot come back … I don’t know doing what’
Some of the participants’ key concerns with screening
were: long waiting-time, the potential to test positive (fear
of outcomes), lack of coping skills or psychosocial support
for those who test positive due to insufficient community
awareness, ‘some are not allowed by their husbands’ to at-
tend clinics and potential for stigma due to disease being
associated with sexuality. Some showed apprehension with
potential for loss of confidentiality, in a case where the ‘staff
attending to me is familiar but I would not want my status
revealed’. These may contribute to reluctance to comply
with follow-up visits among those who test positive.
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screening for cancer of the cervix
Knowledge and awareness of Cancer of the cervix, sources
of risks and its prevention
Clients included those who were referred by clinical
staff, self-referred and others were coming for repeat
testing. Cancer of the cervix was considered as a serious
and ‘disturbing’ condition affecting reproductive organs.
‘It affects the inner part you can’t know, except the
doctor who tests it know what it is’
‘It sucks blood and it causes wound to the affected
area’
They largely associated it with ‘too much sex’ as well as
to familial inheritance, poor genital hygiene, smoking
cigarettes and abortion.
It was related to unusual ‘menstrual-like’ symptoms:
‘you experience abdominal pains, blood and water
comes out; like me an old lady like me I had stopped
giving birth long time ago, I stopped menstruating
many years back, so that it is disturbing me like the
way they’ve screened it, what will they do?’
Their motivation for learning more about the disease
included personal experiences, individual needs and per-
ception of the disease motivated them to them to learn
more about the disease.
‘… like I had not come for the screening [of cancer of
the cervix] and I didn’t know the disease could be
detected, so it is advisable to go for screening even
before seeing the signs’
Disclosure of information at pre-screening and post-test
Pre-test information disclosure
Disclosure was necessary to demystify disease causes:
‘Me, I think that I have better understanding than
before, because I used to know that cancer is caused by
cigarettes, I learnt that the disease is not caused by
cigarettes alone it can be inherited from family
background and also if you see that it’s in your family
lineage its better you go for screening in time so as to
know if you don’t have it or if you have it know how
you can be helped in time’
Majority appreciated that the sessions were private
and confidential and that the information provided was
sufficient. Adequate information enabled them to seek
prompt medical intervention, spiritual and emotional
support.However, others were concerned with lack of information-
giving and being asked questions which were considered as
intrusive, irrelevant or too complex for them to understand:
‘I was asked about the last time I gave birth, but I had
forgotten since it was a long time ago’.
Others indicated that they already knew what they wanted
irrespective of the information received at the clinic.
The participants were concerned with effectiveness of
the test procedures, the possibility that existing symp-
toms similar to that of Cancer of the cervix might com-
plicate the picture and disclosure and sufficiency of the
information disclosed before and after the test results.
Additionally, they raised concern with long wait for re-
sults and difficulty in coping with positive test results.
Post-test information disclosure
Most of the participants felt that test results should be
released promptly, to minimize anxiety, and in a lan-
guage that is easy to understand. Written results were
considered impersonal if not verbally reinforced, espe-
cially since some do not know how to read.
‘you should be told about your results immediately
instead of waiting, since after the test, when not told you
don’t know the results and your heart is not settled’
Some of those who obtained negative test results felt
that they were not given additional relevant information
about the disease and what to do next (possibly feeling
ignored), hence raising concern about the possibility of
false negative test results. Positive test results presented
the greatest challenge to handle, because cancer inher-
ently induces fear, anxiety and loss of hope both to self
and the family in addition to the possibility that the dis-
ease is already advanced. This may be further compli-
cated by inadequate system for care and support:
‘If you know your status, you won’t live long. The shock
will kill you. So you are better off not knowing’
‘When the nurse told me to lie down to be screened,
she said that my case is hard and I had to wait for the
other doctor whom she called to check on me. I believe
in [G]od; so according to [H]is will so be it, am waiting
for the other doctor’
However, some were more confident and optimistic
about their post-test care and coping process:
‘Mmh, now, if they get us with the disease its good
because now I can be given medication, like now I
have been told to come on Tuesday to the clinic’.
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when you come out of that place its you to accept or
deny, but me what I see its good, you accept the result,
come to terms with the situation and leave things to
God and life will not be difficult, but if you live in
denial you will shorten your life span and starts to
regret that I wish I knew , I would not have gone for
this test, and being told about this disease’
Disclosure of known status to relatives
Disclosing the test results to close relations was gener-
ally considered positively because of the potential social
support this would elicit, but this may vary depending
on the bestowed or positional responsibilities in the fam-
ily. It was more preferable for the client herself to di-
vulge the information:
‘I will prefer to be the one to tell them since I know
how they are. Some may be shocked and distressed’.
Informed consent
Participants elicited satisfaction with disclosure of infor-
mation and trust during the procedures as being import-
ant for decision to submit to screening for cancer of the
cervix. However, confidentiality and ‘trust’ in the care-
givers (particularly those familiar to them) not to divulge
personal details was considered crucial in accepting
procedure. To enable them make meaningful decisions
the information disclosed should be relevant, in a lan-
guage that is easy to understand and individualized to
the needs of the clients, sufficient in content with
‘thorough explanations’ to meet the individual’s needs
(depending on health status and the anticipated test-
outcomes), interactive and provided in a welcoming
environment. It was noted that clients may come with
fixed mindset while others may find it difficult to con-
centrate on the information provided about the disease
and the tests.
There was a sense of ‘I am doing this because ‘the doc-
tor had said’, but I don’t have a choice’. A few participants
felt they were ‘pushed’ by the doctor to take the tests. Al-
ternatively, they’d submit because of being already too frail
and desperate for help with their symptoms. Hence, it was
difficult to know whether submitting to a recommended
test was truly voluntary.
Follow up and repeat tests for surveillance
Some participants considered repeat tests necessary to
identify the disease ‘you are suffering from’ is known but,
for some this would be unacceptable:
‘I will not accept [repeat tests] because she tested me
the first time. Is it that she didn’t get it? I am not at
ease since it’s already tested …’Issues related to fear of the disease, ignorance, time bur-
den, cost of travel and staff attitudes were elicited as poten-
tial factors that may compliance with follow up schedules.
Pain and discomfort
Participants may feel discomfort and pain during the
pelvic exam. A few may simultaneously feel uncomfort-
able if the males performed the pelvic examination par-
ticularly those who felt they had no symptoms because
of embarrassment to undress before a ‘stranger’.
‘At first I felt embarrassed when the [male] doctor told
me to undress and climb up the couch [to be done
vaginal exam]; but the doctor talked well and urged
me to be open so as to be helped’.
However, they were reassured by the presence of a fe-
male assistant. Another cause of discomfort associated
with emotional stress was largely due to anxiety during
the long-interval before results were released.
‘… you should be told about your results immediately
instead of waiting, since after the test, when not told
you don’t know the results and your heart is not
settled’
Discussion
Understanding ethical perspectives of public health in-
terventions is necessary to improve decision-making and
address the diverse aspects which may create or exacer-
bate ethical problems [14,36]. The study indicates that
whereas screening may be perceived by some as helpful,
ethical complexities exist in relation to the impact of
both voluntary and compulsory approaches. It is neces-
sary for the national programs to restructure and/or fur-
ther enhance the screening process to mitigate potential
ethical problems as well as improve service uptake.
Pre-screening information disclosure
Pre-screening information disclosure is critical to notify
clients of a mandatory or potentially coercive public health
intervention, its rationale and procedures involved and op-
tions [37]. This is necessary to complement client’s auton-
omy, gain their trust and enjoin them in decision-making
to protect their interest [37]. In this study, screening
process in both approaches involved registration at the ini-
tial encounter, pre-screening health talk; conducting med-
ical and/or laboratory tests; communicating results and
invitation to follow-up visits. The implication of this is that
guidelines to mitigate the ethical challenges can be opera-
tionalized at each stage of the screening process. For ex-
ample the disclosure process can be enhanced by adopting
simple interactive discourse based on appropriate check-
lists or talk-aids, during the process to improve respect for
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messaging would help in illuminating lay understanding,
clarifying notions and shaping decision intentions for on-
going participation in the screening programs [39].
Decision-making and participation in screening
Voluntary choice to participate in screening remains a
subtle issue given the nuances associated with providing
health services within contexts of diverse cultures, inher-
ent inequities and systemic inadequacies [27]. Add-
itionally, interposing gender preferences and relationships,
communication challenges, time burden, nature of tests re-
quired and individual idiosyncrasies complicate decision-
making for participants in compulsory screening. Such
challenges can adversely affect choices during screening
services [40,41].
It was observed that decision to consent for compul-
sory screening was influenced by multiple factors includ-
ing compulsoriness of the procedure, individuals’ lay
knowledge; social biases; sense of personal moral obliga-
tions; pre-screening education talks; pregnancy status;
existing parallel tests; perceived health status and expec-
tations to benefit from disease identification. While
some women were ready to take the tests and easily ap-
proved the exercise, others were not and felt the process
was coercive. Literature on screening shows that object-
ive communication strategies are useful in augmenting
client’s on-going participation in screening can [42,43]
These may include including use of guided communica-
tion aids to improve understanding of target information
[42,43] encourage informed choices. Additionally, priv-
acy and confidentiality should always be guaranteed [44].
The desire for women undergoing compulsory screen-
ing (for Syphilis) to involve their spouses in the process
either by prior information or providing written documen-
tation was aimed to improve decision-making, minimize
forms of prejudice, and enhance disclosure of results. This
indicates the ‘corporate’ aspect of consenting for compul-
sory screening for women, often involving preference from
key family members. It also reinforces the importance of
couple participation in screening process. The goal is to
clarify concerns and promote peer decision support in risk
comprehension among participants [45]. Hence, under-
standing local value norms and inculcating them into the
communication packages can augment compulsory screen
procedures. Croyle and Lerman’s [46] observed that cli-
ents’ decision to seek or accept genetic screen tests and
whether they would recommend it to their kinfolk was in-
formed by their perception of risk, given their experiential
or lay knowledge of the target diseases.
Paternalism versus voluntarism
One of the likely sources of ethical tension in imple-
menting compulsory screening programs is the balancebetween respect for personal choices and preferences to
opt out of the tests vis-à-vis the public health objective
to control syphilis in the population. On the other hand,
under voluntary screening process, a health provider
may be confronted with a dilemma in responding to an
ambivalent client who cedes her decision-making to the
care-giver, ‘trusting’ that a medical staff, would make
‘expert’ decision in their best interest (reasonable stan-
dards criteria). In both cases, the national guidelines
should be clear on how to reasonably proceed. These
tensions demonstrate the inherent complexities encoun-
tered in bid to resolve competing demands between fulfill-
ing client preferences (personal dignity) and professional
obligations to minimizing public health risks (paternalism)
[38,40,47]. Frequently, this position is reinforced by the
power balance in favour of the service provider [48] as
well as the clients’ perceived vulnerability or apparent
helplessness towards diseases viewed as severe, painful,
disturbing or dangerous. Hence, decision-makers and ser-
vice providers need to constantly review national screen-
ing program guidelines and to undergo refresher training
to progressively learn emerging issues.
Confidentiality, privacy and disease notification
Potential conflict exist between regulatory requirement
for mandatory disease diagnosis, treatment, notification
and sufficient follow up/surveillance of Syphilis sero-
positive cases and their partners [7,31,36,49] versus the
concern for confidentiality, client autonomy and poten-
tial prejudice from partners. Primarily, the screening
guidelines should clarify more clearly how staff should
conduct the process and manage the potential dilemmas,
bearing in mind the legal provisions. For example, an al-
gorithm may be provided for quick reference by service
providers. Also, policy-makers at the global or national
policy levels should apply more stringent consider-
ations for balancing benefit and harms when designing
the required guidelines. The goal is to minimize potential
infringement and harm in case individuals plus their fam-
ilies are identified as affected or being at an increased risk
[12]. On the other hand, they should be simple to follow.
Pain, psycho-emotional and social harms associated with
screening
The potential to feel pain, a measure of physical or emo-
tional discomfort during or after procedures, and fear of
being stigmatized due to screening procedures or test
status requires a delicate balance between the health
needs within the prevailing contexts and the goals of the
screening exercise. The ethical requirement is to have
and comply with guidelines, which should be compre-
hensive and displayed for ease of reference [6,7,22,50]
during pre- and post-screening counseling. Additionally,
providing relevant training and regular updates for the
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ing respective screening clinkics should be furnished
with well-designed, comprehensive yet simple to follow
education aids containing information about the target
disease(s) to enhance understanding and allay anxieties.
Receptionists or front desk-staff who are often the first
(and last) contacts with the clients should be appropri-
ately trained and skilled in communication process.
Time burden
Time burden (as a hidden cost) constitutes the period
that clients have to spend going through the entire
process of screening until disclosure of results [51]. Pro-
longed waiting time may potentiate uncertainty or ex-
acerbate clients’ existing apprehensions especially when
no adequate preparation or information is provided.
Also, time could be experienced as problematic for clients,
when limited or lacking, forcing hurried services and pos-
sibly reinforcing their perception of care as impersonal
and insecure. This poses a real barrier to service uptake.
Prolonged travel and waiting time as well as related costs
were barriers to uptake of screening services as they aug-
ment the time burden incurred by clients.
Limitations of the study
The study did not consider the perspectives of the pro-
viders about compulsory and voluntary screening. Hence
it was not possible to know the challenges and how they
resolve them.
The participants interviewed at the clinic were likely a
self-selected group compared to those who don’t attend
services at the health facility, hence need for a field sur-
vey to clarify these aspects.
Conclusions
The context for mounting screening as a public health
intervention and attendant ethical issues may be more
complex than hitherto perceived. The study revealed
that individual context is critical to decision-making.
This indicates that, at the global and operational level,
interpreting emerging ethics issues in screening requires
more nuanced considerations of individuals’ mundane
experiences that are innately intertwined with their trad-
itional and contemporary lore.
It is apparent that in considering mounting screening
for Syphilis (mandatory screening) and cervical cancer
(voluntary screening), the community interests and per-
spectives may be at variance with that of the national
health regulatory and policy frameworks. This is bound
to influence both operational and demand dimensions of
service delivery because of challenges to comply with
prescribed guidelines on one hand and conformity to or
cooperation with the social norms on the other. Besides,
perceived barriers may cause clients to lose opportunitiesto clarify their concerns at the service interface, perhaps
for fear of retribution or communication lapse whereas
the staff may also fail to elicit and mitigate adverse per-
sonal or group experiences during such interactions.
Hence, tensions between voluntarism and paternalism in
screening may be reinforced.
Lack of clear messaging may further influence adversely
the demand for screening services by the individuals at risk
or the community as a collective agent. However, training
on appropriate health education techniques is more likely
to improve intended outputs of screening process. How-
ever, attention should also focus on the unapparent popu-
lations which may potentially influence social behavior.
The current study has also revealed that real harms
exist during screening, whether mandatory or voluntary.
However, effectiveness of the screening approaches vis-
à-vis the harms still require further evaluation across
diseases in different service delivery and geographical
contexts.
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